AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beltran, J.
Right arrow Articles by Kursunoglu-Brahme, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beltran, J.
Right arrow Articles by Kursunoglu-Brahme, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 156, 457-466, Copyright © 1991 by American Roentgen Ray Society

ARTICLES

Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system

J Beltran, V Chandnani, RA McGhee Jr and S Kursunoglu-Brahme
Department of Radiology, Ohio State University Hospitals, Columbus 43210.

Contrast-enhanced MR imaging with gadopentetate dimeglumine has been used in the evaluation of musculoskeletal disorders only in recent years, and for the most part it is still under investigation. Review of the literature identified potential uses for this technique: (1) in the spine, for differentiation between scar tissue and recurrent disk herniation and for evaluation of epidural tumors; (2) in musculoskeletal tumors, for differentiation between tumor necrosis and peritumoral edema and for characterization and evaluation of tumors before and after treatment; (3) in the joints for delineation of cartilage and tendon tears, with intraarticular injection, and for differentiation between pannus and joint effusion, with IV injection; and (4) for delineation of infectious processes. Further studies are needed to confirm most of these potential indications. It is unlikely that gadopentetate dimeglumine-enhanced MR imaging will become a routine part of musculoskeletal MR imaging, and its use will be reserved for specific circumstances.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
C. S. P. van Rijswijk, M. J. A. Geirnaerdt, P. C. W. Hogendoorn, A. H. M. Taminiau, F. van Coevorden, A. H. Zwinderman, T. L. Pope, and J. L. Bloem
Soft-Tissue Tumors: Value of Static and Dynamic Gadopentetate Dimeglumine-enhanced MR Imaging in Prediction of Malignancy
Radiology, November 1, 2004; 233(2): 493 - 502.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Beckers, C. Ribbens, B. Andre, S. Marcelis, O. Kaye, L. Mathy, M.-J. Kaiser, R. Hustinx, J. Foidart, and M. G. Malaise
Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
J. Nucl. Med., June 1, 2004; 45(6): 956 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. J. Kransdorf and M. D. Murphey
Radiologic Evaluation of Soft-Tissue Masses: A Current Perspective
Am. J. Roentgenol., September 1, 2000; 175(3): 575 - 587.
[Full Text] [PDF]

Home page
 RadioGraphicsHome page
M.-S. Sung, H. S. Kang, J. S. Suh, J. H. Lee, J. M. Park, J. Y. Kim, and H. G. Lee
Myxoid Liposarcoma: Appearance at MR Imaging with Histologic Correlation
RadioGraphics, July 1, 2000; 20(4): 1007 - 1019.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Roentgen Ray Society.